Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Biofilm matrix polysaccharides with β 1–6 N-acetylglucosamine linkages, such as poly-β-(1-6)-N-acetylglucosamine (PNAG), are crucial components of bacterial biofilms. They contribute to adhesion, structural integrity, and protection against environmental stressors, host immune responses, and antimicrobial agents. Targeting these polysaccharides is a promising strategy for developing novel anti-biofilm therapies.
Targeted disruption of biofilm formation or matrix structure. Antibody-mediated biofilm dispersal.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biofilm Matrix Polysaccharide (β 1–6 N-acetylglucosamine linkage) (PNAG).